Lilly Zyprexa IM Agitation Use Should Be Limited To Patients Studied In Trials
Executive Summary
Lilly's antipsychotic Zyprexa intramuscular injection is safe and effective for the treatment of agitation in schizophrenia, bipolar I disorder and dementia, FDA's Psychopharmacological Drugs Advisory Committee concluded in a unanimous vote Feb. 14.